Demand of surgical component in complex treatment metastatic bone disease
Abstract
Purpose. To estimate the relevance of surgical treatment of patients with metastatic bone disease.
Materials and methods. from april 2015 to april 2016, we have consulted 231 patients with metastatic bone disease.
Results. We performed 107 operations in 74 patients from which minimally invasive techniques performed in 53 (71%) patients. Spine stabilizing operations and bone resections conducted in 21 (29%) of patients.
Conclusion. The demand of orthopedic treatment in patients with metastatic bone disease is 35%. Without minimally invasive techniques, this value is 9%. There were no significant complications after performed surgeries in all groups. pain has decreased fully or partially in 66 (89%) of patients. neurologic status has improved in 8 of 12 (66%) of subjects. Increased ECOG and MSTS functional status was observed in 18 of 74 (24%) and 7 of 10 (70%) of patients respectively.
About the Authors
V. V. Teplyakov
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
A. A. Shaposhnikov
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
P. S. Sergeev
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
A. O. Akhov
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
Y. A. Li
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
A. V. Lazukin
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
D. V. Baryshnikova
Federal State Budget Institution «Russian Scientific Centre of Roentgen Radiology» of the Russian Federation Health Ministry
Russian Federation
Russian Federation
Moscow
References
1. Тепляков В.В., Алиев М.Д. Руководство по онкологии. Под ред. В.И. Чиссова, С.Л. Дарьяловой. М.: ООО «Медицинское информационное агентство». 2008, гл. 42, с. 680-693.
2. Тепляков В.В. Чрескостный остеосинтез в лечении больных с первичными злокачественными и метастатическими опухолями длинных трубчатых костей. Диссертация на соискание степени д-ра мед. наук. М., 2000, 272 с.
3. Алиев М.Д., Тепляков В.В., Каллистов В.Е. и соавт. Современные подходы к хирургическому лечению метастазов злокачественных опухолей в кости. Практическая онкология: избранные лекции. Под ред. С.А.Тюляндина, В.М. Моисеенко. СПб.: Центр ТОММ. 2004, с. 738-748.
4. Rikard Wedin, M.D., Henrik C.F. Bauer, Lars-Erik Rutqvist. Surgical Treatment for Skeletal Breast Cancer Metastases. Cancer. 2001, v. 92, No. 2, p. 257-262.
5. Michael Kuchuk, Christina L. Addison, Mark Clemons et al. Incidence and consequences of bone metastases in lung cancer patients. Journal of Bone Oncology. 2013, p. 24.
6. Kirsten Steinauer, Dorothy Jane Huang, Serenella Eppenberger-Castori et al. Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy. Journal of Bone Oncology. 2014, p. 57.
7. Fottner A. et al. Bone metastases from renal cell carcinoma: Patient survival after surgical treatment. BMC Musculoskeletal Disorders. 2010, 11.
8. Colleen et al. Bone metastases. 2012, chapter 33, p. 591-609.
9. Weiss J., Jonathan A. Forsberg, Rikard Wedin. Surgery of skeletal metastases in 306 patients with prostate cancer. Acta Orthopaedica. 2012, v. 83 (1), p. 74-79.
10. Buggay D., Jaffe K. Metastatic bone tumors of the pelvis and lower extremity. J. Surg. Orthop. Adv. 2003, v. 12, p. 192.
11. Maria N. Kirkinis et al. Metastatic bone disease: A review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton. European Journal of Surgical Oncology. 2016, p. 24.
12. Robert E. Coleman. Bisphosphonates: Clinical Experience. The Oncologist. 2004, p. 15.
13. Motzer R.J. et al. Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma. BJC. 2013, v. 108 (12), p. 2470-2477.
14. Maire Ratasvuori, Rikard Wedin, Johnny Keller et al. Insight opinion to surgically treated metastatic bone disease:Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surgical Oncology. 2013, v. 22, p. 132-138.
15. Patrick P. Lin, MD, Attiqa N. Mirza et al. Patient Survival After Surgery for Osseous Metastases from Renal Cell Carcinoma, The journal of bone and joint surgery, incorporated. 2007, p. 1794-1801.
Review
For citations:
Teplyakov V.V., Shaposhnikov A.A., Sergeev P.S., Akhov A.O., Li Y.A., Lazukin A.V., Baryshnikova D.V. Demand of surgical component in complex treatment metastatic bone disease. Bone and soft tissue sarcomas, tumors of the skin. 2016;(1):16-28. (In Russ.)
Views:
138
Email this article 
